266 related articles for article (PubMed ID: 31073087)
1. Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.
Ulrich S; Saxer S; Hasler ED; Schwarz EI; Schneider SR; Furian M; Bader PR; Lichtblau M; Bloch KE
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31073087
[TBL] [Abstract][Full Text] [Related]
2. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
[TBL] [Abstract][Full Text] [Related]
3. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
[TBL] [Abstract][Full Text] [Related]
4. Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.
Gerhardt F; Dumitrescu D; Gärtner C; Beccard R; Viethen T; Kramer T; Baldus S; Hellmich M; Schönau E; Rosenkranz S
Heart; 2017 Apr; 103(8):592-598. PubMed ID: 28100544
[TBL] [Abstract][Full Text] [Related]
5. The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial.
Müller J; Titz A; Schneider SR; Bauer M; Mayer L; Lüönd L; Ulrich T; Furian M; Forrer A; Schwarz EI; Bloch KE; Lichtblau M; Ulrich S
Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38423623
[TBL] [Abstract][Full Text] [Related]
6. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia.
McDonald CF; Blyth CM; Lazarus MD; Marschner I; Barter CE
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1616-9. PubMed ID: 7582304
[TBL] [Abstract][Full Text] [Related]
7. Exercise capacity affects quality of life in patients with pulmonary hypertension.
Halank M; Einsle F; Lehman S; Bremer H; Ewert R; Wilkens H; Meyer FJ; Grünig E; Seyfarth HJ; Kolditz M; Wieder G; Höffken G; Köllner V
Lung; 2013 Aug; 191(4):337-43. PubMed ID: 23681593
[TBL] [Abstract][Full Text] [Related]
8. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
[TBL] [Abstract][Full Text] [Related]
9. Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.
Ulrich S; Hasler ED; Saxer S; Furian M; Müller-Mottet S; Keusch S; Bloch KE
Eur Heart J; 2017 Apr; 38(15):1159-1168. PubMed ID: 28329240
[TBL] [Abstract][Full Text] [Related]
10. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
11. Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
Berlier C; Schwarz EI; Saxer S; Lichtblau M; Ulrich S
Lung; 2019 Jun; 197(3):353-360. PubMed ID: 30963265
[TBL] [Abstract][Full Text] [Related]
12. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F
Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271
[TBL] [Abstract][Full Text] [Related]
13. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
14. Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial.
Ulrich S; Keusch S; Hildenbrand FF; Lo Cascio C; Huber LC; Tanner FC; Speich R; Bloch KE
Eur Heart J; 2015 Mar; 36(10):615-23. PubMed ID: 24366914
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.
Vizza CD; Jansa P; Teal S; Dombi T; Zhou D
BMC Cardiovasc Disord; 2017 Sep; 17(1):239. PubMed ID: 28874133
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of exercise training and rehabilitation in chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
An QY; Wang L; Yuan P; Zhao QH; Gong SG; Zhang R; He J; Luo CJ; Qiu HL; Li HT; Liu JM; Wang JJ; Cheng K; Jiang R
Ann Palliat Med; 2021 Jul; 10(7):8134-8146. PubMed ID: 34353098
[TBL] [Abstract][Full Text] [Related]
17. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
Goudie AR; Lipworth BJ; Hopkinson PJ; Wei L; Struthers AD
Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to exercise capacity in chronic thromboembolic pulmonary hypertension with near-normal hemodynamics.
Tobita K; Goda A; Nishida Y; Takeuchi K; Kikuchi H; Inami T; Kohno T; Yamada S; Soejima K; Satoh T
J Heart Lung Transplant; 2021 Jul; 40(7):677-686. PubMed ID: 33879384
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
20. Step climbing capacity in patients with pulmonary hypertension.
Fox BD; Langleben D; Hirsch A; Boutet K; Shimony A
Clin Res Cardiol; 2013 Jan; 102(1):51-61. PubMed ID: 22875547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
